Medexus Pharmaceuticals (MDP) News Today C$2.87 -0.12 (-4.01%) As of 02/21/2025 03:59 PM Eastern Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider Trades All Sources Trusted Sources MarketBeat Benzinga Bloomberg GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 Time Period Medexus Pharmaceuticals Inc. (TSE:MDP) Receives Consensus Recommendation of "Buy" from BrokeragesFebruary 15, 2025 | americanbankingnews.comMedexus Pharmaceuticals Inc. (TSE:MDP) Given Consensus Recommendation of "Buy" by BrokeragesMedexus Pharmaceuticals Inc. (TSE:MDP - Get Free Report) has been assigned an average rating of "Buy" from the seven analysts that are presently covering the company, Marketbeat.com reports. Two research analysts have rated the stock with a hold recommendation, one has given a buy recommendation aFebruary 15, 2025 | marketbeat.comFY2026 Earnings Estimate for TSE:MDP Issued By Stifel CanadaFebruary 12, 2025 | americanbankingnews.comRaymond James Issues Negative Estimate for TSE:MDP EarningsMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Research analysts at Raymond James reduced their Q4 2026 earnings per share (EPS) estimates for shares of Medexus Pharmaceuticals in a report released on Thursday, February 6th. Raymond James analyst M. Freeman now expects that the company wiFebruary 10, 2025 | marketbeat.comStifel Canada Estimates TSE:MDP FY2026 EarningsMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Equities research analysts at Stifel Canada issued their FY2026 EPS estimates for shares of Medexus Pharmaceuticals in a report issued on Thursday, February 6th. Stifel Canada analyst J. Keywood forecasts that the company will post earnings oFebruary 10, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Lowered to "Hold" Rating by Stifel CanadaStifel Canada cut shares of Medexus Pharmaceuticals from a "strong-buy" rating to a "hold" rating in a research note on Thursday.February 8, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Downgraded to Hold Rating by Stifel NicolausStifel Nicolaus cut shares of Medexus Pharmaceuticals from a "buy" rating to a "hold" rating and reduced their price target for the stock from C$6.00 to C$3.45 in a research report on Friday.February 7, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Stock Price Down 13.2% - Time to Sell?Medexus Pharmaceuticals (TSE:MDP) Trading Down 13.2% - Here's WhyFebruary 6, 2025 | marketbeat.comWhat is Raymond James' Estimate for TSE:MDP FY2025 Earnings?Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Research analysts at Raymond James boosted their FY2025 earnings estimates for Medexus Pharmaceuticals in a research note issued to investors on Monday, February 3rd. Raymond James analyst M. Freeman now forecasts that the company will earn $February 6, 2025 | marketbeat.comWhat is Raymond James' Forecast for TSE:MDP FY2027 Earnings?Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Equities researchers at Raymond James cut their FY2027 earnings per share estimates for shares of Medexus Pharmaceuticals in a research note issued to investors on Monday, February 3rd. Raymond James analyst M. Freeman now expects that the coFebruary 5, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Price Target Raised to C$6.25Ventum Financial raised their price target on Medexus Pharmaceuticals from C$5.00 to C$6.25 and gave the stock a "buy" rating in a research report on Thursday.January 30, 2025 | marketbeat.comStifel Nicolaus Issues Positive Forecast for Medexus Pharmaceuticals (TSE:MDP) Stock PriceStifel Nicolaus raised their price objective on Medexus Pharmaceuticals from C$4.50 to C$6.00 in a research note on Thursday.January 30, 2025 | marketbeat.comCanadian Investment Regulatory Organization Trading Halt - MDPJanuary 29, 2025 | finance.yahoo.comCanadian Investment Regulatory Organization Trade Resumption - MDPJanuary 29, 2025 | ca.finance.yahoo.comMedexus Pharmaceuticals (TSE:MDP) Stock Price Down 6.5% - Time to Sell?Medexus Pharmaceuticals (TSE:MDP) Shares Down 6.5% - What's Next?January 28, 2025 | marketbeat.comQ1 Earnings Estimate for TSE:MDP Issued By Ventum Cap MktsMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Investment analysts at Ventum Cap Mkts increased their Q1 2026 earnings per share estimates for Medexus Pharmaceuticals in a report issued on Wednesday, January 22nd. Ventum Cap Mkts analyst M. Czmielewski now forecasts that the company willJanuary 27, 2025 | marketbeat.comEquities Analysts Set Expectations for TSE:MDP Q3 EarningsMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Stock analysts at Bloom Burton lifted their Q3 2025 earnings per share estimates for shares of Medexus Pharmaceuticals in a research note issued on Thursday, January 23rd. Bloom Burton analyst D. Martin now forecasts that the company will earJanuary 27, 2025 | marketbeat.comFY2026 EPS Estimates for TSE:MDP Lifted by Leede FinancialMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Research analysts at Leede Financial raised their FY2026 earnings per share (EPS) estimates for shares of Medexus Pharmaceuticals in a report released on Wednesday, January 22nd. Leede Financial analyst D. Loe now forecasts that the company wJanuary 24, 2025 | marketbeat.comResearch Analysts Set Expectations for TSE:MDP Q4 EarningsMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Equities research analysts at Bloom Burton decreased their Q4 2025 earnings per share (EPS) estimates for Medexus Pharmaceuticals in a note issued to investors on Thursday, January 23rd. Bloom Burton analyst D. Martin now anticipates that theJanuary 24, 2025 | marketbeat.comTSE:MDP FY2025 EPS Estimate Lifted by Leede FinancialMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Leede Financial upped their FY2025 earnings per share estimates for shares of Medexus Pharmaceuticals in a research report issued to clients and investors on Wednesday, January 22nd. Leede Financial analyst D. Loe now forecasts that the compaJanuary 23, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Upgraded to Strong-Buy at Leede FinancialLeede Financial raised shares of Medexus Pharmaceuticals from a "moderate buy" rating to a "strong-buy" rating in a report on Wednesday.January 23, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Shares Up 38.6% - Here's What HappenedMedexus Pharmaceuticals (TSE:MDP) Stock Price Up 38.6% - Still a Buy?January 22, 2025 | marketbeat.comMedexus Pharmaceuticals Inc. (TSE:MDP) Receives Average Rating of "Strong Buy" from AnalystsShares of Medexus Pharmaceuticals Inc. (TSE:MDP - Get Free Report) have been assigned an average rating of "Strong Buy" from the six ratings firms that are presently covering the firm, MarketBeat Ratings reports. Two investment analysts have rated the stock with a buy recommendation and four have iJanuary 21, 2025 | marketbeat.comFY2025 Earnings Estimate for TSE:MDP Issued By Stifel CanadaMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Analysts at Stifel Canada lifted their FY2025 earnings per share (EPS) estimates for shares of Medexus Pharmaceuticals in a research report issued to clients and investors on Monday, January 13th. Stifel Canada analyst J. Keywood now anticipaJanuary 16, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Reaches New 52-Week High on Analyst UpgradeMedexus Pharmaceuticals (TSE:MDP) Sets New 12-Month High Following Analyst UpgradeJanuary 15, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Stock Price Expected to Rise, Stifel Nicolaus Analyst SaysStifel Nicolaus upped their price target on shares of Medexus Pharmaceuticals from C$4.15 to C$4.50 in a report on Tuesday.January 14, 2025 | marketbeat.comRaymond James Issues Negative Forecast for TSE:MDP EarningsMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Analysts at Raymond James reduced their Q3 2025 earnings per share estimates for Medexus Pharmaceuticals in a report released on Tuesday, January 7th. Raymond James analyst M. Freeman now anticipates that the company will post earnings of ($0January 10, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Hits New 52-Week High - What's Next?Medexus Pharmaceuticals (TSE:MDP) Reaches New 12-Month High - Time to Buy?January 9, 2025 | marketbeat.comRaymond James Has Pessimistic Outlook of TSE:MDP Q3 EarningsMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Research analysts at Raymond James decreased their Q3 2026 earnings per share estimates for shares of Medexus Pharmaceuticals in a research report issued on Tuesday, January 7th. Raymond James analyst M. Freeman now expects that the company wJanuary 9, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Stock Rating Upgraded by Raymond JamesRaymond James upgraded Medexus Pharmaceuticals from an "outperform" rating to a "strong-buy" rating and set a C$4.00 target price on the stock in a research note on Wednesday.January 8, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Reaches New 1-Year High - Here's What HappenedMedexus Pharmaceuticals (TSE:MDP) Sets New 52-Week High - Time to Buy?January 3, 2025 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Reaches New 1-Year High - Should You Buy?Medexus Pharmaceuticals (TSE:MDP) Hits New 52-Week High - Here's What HappenedDecember 27, 2024 | marketbeat.comMedexus Pharmaceuticals Inc. (TSE:MDP) Receives Average Rating of "Buy" from BrokeragesShares of Medexus Pharmaceuticals Inc. (TSE:MDP - Get Free Report) have been given an average recommendation of "Buy" by the five analysts that are currently covering the company, MarketBeat.com reports. Three analysts have rated the stock with a buy rating and two have given a strong buy rating toDecember 27, 2024 | marketbeat.comDespite the downward trend in earnings at Medexus Pharmaceuticals (TSE:MDP) the stock spikes 16%, bringing one-year gains to 48%December 25, 2024 | finance.yahoo.comEquities Analysts Issue Forecasts for TSE:MDP Q3 EarningsMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Raymond James issued their Q3 2025 EPS estimates for shares of Medexus Pharmaceuticals in a research report issued on Tuesday, November 19th. Raymond James analyst M. Freeman forecasts that the company will post earnings of $0.01 per share foNovember 22, 2024 | marketbeat.comRaymond James Predicts TSE:MDP FY2029 EarningsMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Equities researchers at Raymond James issued their FY2029 earnings per share estimates for shares of Medexus Pharmaceuticals in a report released on Tuesday, November 19th. Raymond James analyst R. Sarugaser forecasts that the company will poNovember 21, 2024 | marketbeat.comLeede Financial Issues Negative Outlook for TSE:MDP EarningsMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Stock analysts at Leede Financial lowered their FY2026 earnings estimates for Medexus Pharmaceuticals in a report issued on Friday, November 8th. Leede Financial analyst D. Loe now anticipates that the company will post earnings per share ofNovember 11, 2024 | marketbeat.comShould We Be Cautious About Medexus Pharmaceuticals Inc.'s (TSE:MDP) ROE Of 7.0%?November 10, 2024 | finance.yahoo.comMedexus Pharmaceuticals Inc (TSX:MDP) Q2 2025: Everything You Need to Know Ahead of EarningsNovember 7, 2024 | finance.yahoo.comMedexus Pharmaceuticals Inc (TSX:MDP) Q2 2025 Earnings Report Preview: What To Look ForNovember 6, 2024 | finance.yahoo.comMedexus Pharmaceuticals (MDP) Set to Announce Earnings on ThursdayMedexus Pharmaceuticals (TSE:MDP) will be releasing earnings after the market closes on Thursday, November 7, Zacks reports.October 31, 2024 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Trading Up 1.6% - Should You Buy?Medexus Pharmaceuticals (TSE:MDP) Trading 1.6% Higher - Here's WhyOctober 24, 2024 | marketbeat.comAnalysts Issue Forecasts for Medexus Pharmaceuticals Inc.'s Q2 2025 Earnings (TSE:MDP)Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Analysts at Leede Financial issued their Q2 2025 earnings estimates for shares of Medexus Pharmaceuticals in a research note issued to investors on Monday, September 30th. Leede Financial analyst D. Loe forecasts that the company will post eaOctober 2, 2024 | marketbeat.comLeede Financial Reiterates "C$8.25" Price Target for Medexus Pharmaceuticals (TSE:MDP)Leede Financial set a C$8.25 price objective on shares of Medexus Pharmaceuticals and gave the company a "speculative buy" rating in a research note on Monday.September 30, 2024 | marketbeat.comVentum Cap Mkts Equities Analysts Reduce Earnings Estimates for Medexus Pharmaceuticals Inc. (TSE:MDP)Medexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Ventum Cap Mkts lowered their FY2025 earnings per share estimates for Medexus Pharmaceuticals in a research note issued on Monday, September 16th. Ventum Cap Mkts analyst S. Quenneville now expects that the company will earn $0.24 per share fSeptember 19, 2024 | marketbeat.comFDA extends review period for Medexus' treosulfan to 2025September 16, 2024 | msn.comMedexus Pharmaceuticals (TSE:MDP) Stock Price Down 19.4%Medexus Pharmaceuticals (TSE:MDP) Trading Down 19.4%September 16, 2024 | marketbeat.comMedexus Pharmaceuticals (TSE:MDP) Shares Up 6.6%Medexus Pharmaceuticals (TSE:MDP) Trading Up 6.6%September 5, 2024 | marketbeat.comSome May Be Optimistic About Medexus Pharmaceuticals' (TSE:MDP) EarningsAugust 20, 2024 | finance.yahoo.comQ3 2025 EPS Estimates for Medexus Pharmaceuticals Inc. (TSE:MDP) Lowered by AnalystMedexus Pharmaceuticals Inc. (TSE:MDP - Free Report) - Research analysts at Bloom Burton dropped their Q3 2025 earnings per share (EPS) estimates for shares of Medexus Pharmaceuticals in a research note issued to investors on Friday, August 9th. Bloom Burton analyst D. Martin now expects that theAugust 12, 2024 | marketbeat.com Get Medexus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDP and its competitors with MarketBeat's FREE daily newsletter. Email Address MDP Media Mentions By Week MDP Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. MDP News Sentiment▼0.510.60▲Average Medical News Sentiment MDP News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. MDP Articles This Week▼01▲MDP Articles Average Week Get Medexus Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for MDP and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies Organigram News Today Canopy Growth News Today Cardiol Therapeutics News Today HLS Therapeutics News Today BioSyent News Today Decibel Cannabis News Today MediPharm Labs News Today Charlotte's Web News Today Crescita Therapeutics News Today Medicure News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (TSE:MDP) was last updated on 2/22/2025 by MarketBeat.com Staff From Our PartnersSecret financial plot unfolding in Washington DC… [DEVELOPING]What stocks are next up to soar in 2025? I believe I’ve found the answer - and it might surprise you. Yo...Timothy Sykes | SponsoredBuy NVDA Now? After weeks of volatility, did President Trump just turn Nvidia (NVDA) into a raging BUY? The beloved chip...Chaikin Analytics | SponsoredElon’s “New Gold”MIT scientists just developed a brand-new metal… A metal that’s shaping up to be, not only the biggest brea...True Market Insiders | SponsoredWhy Buffett and 100 members of Congress are Piling into this One InvestmentThis isn't just another investment. It might be the last retirement stock you'll ever need. But this win...Behind the Markets | SponsoredBuy this AI Stock Before Elon’s AnnouncementWith Trump back in office, xAI is primed to become the leader in generative AI, leaving competitors in the dus...InvestorPlace | SponsoredMarket down? Do this now.During Trump's first term, his tariffs sent gold prices soaring. Investors who acted early made a fortune. Now...Colonial Metals | SponsoredThis Crypto Is Set to Explode in FebruaryIt's a groundbreaking opportunity that could be poised for extraordinary gains. The catalyst behind this su...Crypto 101 Media | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Medexus Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Medexus Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free MDP Stock Alerts